Articles by tag: biotech-analysis

Breakthrough in Parkinson's Disease Treatment: JOTROL US Trials

Critical Analysis of Jupiter Neurosciences' Phase 2a JOTROL: Bioavailability, Finances, Supplements, and Hidden Risks. Read Before Believing the Breakthrough.

Reqorsa Gene Therapy: Analysis of ASCO-2026 Data and Prospects

Critical analysis of Reqorsa gene therapy results at ASCO-2026: sample of 18 patients, p=0.05, risks for investors and the real situation of Genprex. Read details.